-
3
-
-
21244499844
-
Surgical salvage of recurrent rectal cancer after transanal excision
-
Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005;48:1169-1175.
-
(2005)
Dis Colon Rectum
, vol.48
, pp. 1169-1175
-
-
Weiser, M.R.1
Landmann, R.G.2
Wong, W.D.3
-
4
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
5
-
-
84875518109
-
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
-
Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2009:CD006041.
-
(2009)
Cochrane Database Syst Rev
-
-
Ceelen, W.P.1
Van Nieuwenhove, Y.2
Fierens, K.3
-
6
-
-
84864143836
-
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?
-
Bonnetain F, Bosset JF, Gerard JP, et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer 2012;48:1781-1790.
-
(2012)
Eur J Cancer
, vol.48
, pp. 1781-1790
-
-
Bonnetain, F.1
Bosset, J.F.2
Gerard, J.P.3
-
7
-
-
33748676449
-
Chemotherapy with preoperative radiotherapy in rectal cancer
-
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123.
-
(2006)
N Engl J Med
, vol.355
, pp. 1114-1123
-
-
Bosset, J.F.1
Collette, L.2
Calais, G.3
-
8
-
-
24944499364
-
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921
-
Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 2005;23:5620-5627.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5620-5627
-
-
Bosset, J.F.1
Calais, G.2
Mineur, L.3
-
9
-
-
33750580102
-
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203
-
Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-4625.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4620-4625
-
-
Gerard, J.P.1
Conroy, T.2
Bonnetain, F.3
-
10
-
-
79956288407
-
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer
-
Park JH, Yoon SM, Yu CS, et al. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer 2011;117:3703-3712.
-
(2011)
Cancer
, vol.117
, pp. 3703-3712
-
-
Park, J.H.1
Yoon, S.M.2
Yu, C.S.3
-
11
-
-
70449726857
-
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03
-
Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-5130.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5124-5130
-
-
Roh, M.S.1
Colangelo, L.H.2
O'Connell, M.J.3
-
12
-
-
84860918386
-
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the german CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years
-
Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the german CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30:1926-1933.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1926-1933
-
-
Sauer, R.1
Liersch, T.2
Merkel, S.3
-
13
-
-
33947707199
-
Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: A review
-
Klautke G, Fietkau R. Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review. Int J Colorectal Dis 2007;22:457-465.
-
(2007)
Int J Colorectal Dis
, vol.22
, pp. 457-465
-
-
Klautke, G.1
Fietkau, R.2
-
14
-
-
67650315187
-
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
-
Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009;27:3109-3116.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3109-3116
-
-
Andre, T.1
Boni, C.2
Navarro, M.3
-
15
-
-
34250210799
-
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
-
Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198-2204.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2198-2204
-
-
Kuebler, J.P.1
Wieand, H.S.2
O'Connell, M.J.3
-
16
-
-
0242578674
-
Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer
-
Zhu AX, Willett CG. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. Semin Radiat Oncol 2003;13:454-468.
-
(2003)
Semin Radiat Oncol
, vol.13
, pp. 454-468
-
-
Zhu, A.X.1
Willett, C.G.2
-
17
-
-
84864950700
-
Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: What have we learned from a decade of translational research?
-
Hill EJ, Nicolay NH, Middleton MR, Sharma RA. Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research? Crit Rev Oncol Hematol 2012;83:353-387.
-
(2012)
Crit Rev Oncol Hematol
, vol.83
, pp. 353-387
-
-
Hill, E.J.1
Nicolay, N.H.2
Middleton, M.R.3
Sharma, R.A.4
-
18
-
-
0037304502
-
Chemoradiotherapy: Emerging treatment improvement strategies
-
Milas L, Mason KA, Liao Z, Ang KK. Chemoradiotherapy: emerging treatment improvement strategies. Head Neck 2003;25:152-167.
-
(2003)
Head Neck
, vol.25
, pp. 152-167
-
-
Milas, L.1
Mason, K.A.2
Liao, Z.3
Ang, K.K.4
-
19
-
-
0032962339
-
Radiopotentiation by the oral platinum agent, JM216: Role of repair inhibition
-
Amorino GP, Freeman ML, Carbone DP, et al. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. Int J Radiat Oncol Biol Phys 1999;44:399-405.
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 399-405
-
-
Amorino, G.P.1
Freeman, M.L.2
Carbone, D.P.3
-
20
-
-
0037086328
-
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule
-
Cividalli A, Ceciarelli F, Livdi E, et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 2002;52:1092-1908.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 1092-1908
-
-
Cividalli, A.1
Ceciarelli, F.2
Livdi, E.3
-
21
-
-
0008590833
-
Oxaliplatin: In vitro and in vivo evidence of its radiation sensitizing activity - Preclinical observations relevant to ongoing trials [abstract]
-
Hess S, Blackstock AW. Oxaliplatin: in vitro and in vivo evidence of its radiation sensitizing activity - preclinical observations relevant to ongoing trials [abstract]. Proc Am Assoc Cancer Res 2000;41:Abstract A335.
-
(2000)
Proc Am Assoc Cancer Res
, vol.41
-
-
Hess, S.1
Blackstock, A.W.2
-
22
-
-
0141954386
-
Oxaliplatin: In vitro evidence of its radiation sensitizing activity - Preclinical observations relevant to clinical trials
-
Blackstock AW, Hess S, Chaney S, Tepper JE. Oxaliplatin: in vitro evidence of its radiation sensitizing activity - preclinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys 1999;45:253-254.
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.45
, pp. 253-254
-
-
Blackstock, A.W.1
Hess, S.2
Chaney, S.3
Tepper, J.E.4
-
23
-
-
0037262142
-
Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status
-
Magne N, Fischel JL, Formento P, et al. Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status. Oncology 2003;64:280-287.
-
(2003)
Oncology
, vol.64
, pp. 280-287
-
-
Magne, N.1
Fischel, J.L.2
Formento, P.3
-
24
-
-
27644493797
-
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: A colorectal clinical oncology group (CCOG) study
-
Sebag-Montefiore D, Glynne-Jones R, Falk S, et al. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a colorectal clinical oncology group (CCOG) study. Br J Cancer 2005;93:993-998.
-
(2005)
Br J Cancer
, vol.93
, pp. 993-998
-
-
Sebag-Montefiore, D.1
Glynne-Jones, R.2
Falk, S.3
-
25
-
-
29844435015
-
A phase i dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
-
Glynne-Jones R, Sebag-Montefiore D, Maughan TS, et al. A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-56.
-
(2006)
Ann Oncol
, vol.17
, pp. 50-56
-
-
Glynne-Jones, R.1
Sebag-Montefiore, D.2
Maughan, T.S.3
-
26
-
-
0035340318
-
Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 phase i trial
-
Freyer G, Bossard N, Romestaing P, et al. Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 2001;19:2433-2438.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2433-2438
-
-
Freyer, G.1
Bossard, N.2
Romestaing, P.3
-
27
-
-
33745005080
-
Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901
-
Ryan DP, Niedzwiecki D, Hollis D, et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006;24:2557-2562.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2557-2562
-
-
Ryan, D.P.1
Niedzwiecki, D.2
Hollis, D.3
-
28
-
-
0041912759
-
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer
-
Rodel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003;21:3098-3104.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3098-3104
-
-
Rodel, C.1
Grabenbauer, G.G.2
Papadopoulos, T.3
-
29
-
-
25444503968
-
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer
-
Aschele C, Friso ML, Pucciarelli S, et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005;16:1140-1146.
-
(2005)
Ann Oncol
, vol.16
, pp. 1140-1146
-
-
Aschele, C.1
Friso, M.L.2
Pucciarelli, S.3
-
30
-
-
28244443399
-
Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: A phase i study
-
Francois E, Ychou M, Ducreux M, et al. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study. Eur J Cancer 2005;41:2861-2867.
-
(2005)
Eur J Cancer
, vol.41
, pp. 2861-2867
-
-
Francois, E.1
Ychou, M.2
Ducreux, M.3
-
31
-
-
49549098631
-
Phase i study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297
-
Rosenthal DI, Catalano PJ, Haller DG, et al. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297. Int J Radiat Oncol Biol Phys 2008;72:108-113.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 108-113
-
-
Rosenthal, D.I.1
Catalano, P.J.2
Haller, D.G.3
-
32
-
-
33748566796
-
A phase i study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
-
Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;65:1462-1470.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1462-1470
-
-
Fakih, M.G.1
Rajput, A.2
Yang, G.Y.3
-
33
-
-
20144379288
-
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: A phase i trial
-
Loi S, Ngan SY, Hicks RJ, et al. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer 2005;92:655-661.
-
(2005)
Br J Cancer
, vol.92
, pp. 655-661
-
-
Loi, S.1
Ngan, S.Y.2
Hicks, R.J.3
-
34
-
-
16344362642
-
Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase i study
-
Reerink O, Mulder NH, Verschueren RC, et al. Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study. Anticancer Res 2005;25:629-633.
-
(2005)
Anticancer Res
, vol.25
, pp. 629-633
-
-
Reerink, O.1
Mulder, N.H.2
Verschueren, R.C.3
-
35
-
-
0037445116
-
Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial
-
Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-1124.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1119-1124
-
-
Gerard, J.P.1
Chapet, O.2
Nemoz, C.3
-
36
-
-
28444461463
-
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study
-
Machiels JP, Duck L, Honhon B, et al. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann Oncol 2005;16:1898-1905.
-
(2005)
Ann Oncol
, vol.16
, pp. 1898-1905
-
-
MacHiels, J.P.1
Duck, L.2
Honhon, B.3
-
37
-
-
52949095388
-
Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma
-
Fakih MG, Bullarddunn K, Yang GY, et al. Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2008;72:650-657.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 650-657
-
-
Fakih, M.G.1
Bullarddunn, K.2
Yang, G.Y.3
-
38
-
-
34648814228
-
Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the dutch colorectal cancer group
-
Hospers GA, Punt CJ, Tesselaar ME, et al. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the dutch colorectal cancer group. Ann Surg Oncol 2007;14:2773-2779.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 2773-2779
-
-
Hospers, G.A.1
Punt, C.J.2
Tesselaar, M.E.3
-
39
-
-
0036803131
-
Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: A phase II IATTGI study
-
Carraro S, Roca EL, Cartelli C, et al. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 2002;54:397-402.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 397-402
-
-
Carraro, S.1
Roca, E.L.2
Cartelli, C.3
-
40
-
-
0842326026
-
Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas
-
Feng WH, Hong G, Delecluse HJ, Kenney SC. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J Virol 2004;78:1893-1902.
-
(2004)
J Virol
, vol.78
, pp. 1893-1902
-
-
Feng, W.H.1
Hong, G.2
Delecluse, H.J.3
Kenney, S.C.4
-
41
-
-
32844470492
-
Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer
-
Turitto G, Panelli G, Frattolillo A, et al. Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer. Front Biosci 2006;11:1275-1279.
-
(2006)
Front Biosci
, vol.11
, pp. 1275-1279
-
-
Turitto, G.1
Panelli, G.2
Frattolillo, A.3
-
42
-
-
33751268959
-
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer
-
Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006;32:1201-1208.
-
(2006)
Eur J Surg Oncol
, vol.32
, pp. 1201-1208
-
-
Urso, E.1
Serpentini, S.2
Pucciarelli, S.3
-
43
-
-
69849105558
-
Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma
-
Feng HY, Li DC, Lou RC, et al. Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2005;8:125-128.
-
(2005)
Zhonghua Wei Chang Wai Ke Za Zhi
, vol.8
, pp. 125-128
-
-
Feng, H.Y.1
Li, D.C.2
Lou, R.C.3
-
44
-
-
33747874014
-
Alternative clinical end points in rectal cancer - are we getting closer?
-
Glynne-Jones R, Mawdsley S, Pearce T, Buyse M. Alternative clinical end points in rectal cancer - are we getting closer? Ann Oncol 2006;17:1239-1248.
-
(2006)
Ann Oncol
, vol.17
, pp. 1239-1248
-
-
Glynne-Jones, R.1
Mawdsley, S.2
Pearce, T.3
Buyse, M.4
-
45
-
-
33748566796
-
A phase i study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
-
Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006;65:1462-1470.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1462-1470
-
-
Fakih, M.G.1
Rajput, A.2
Yang, G.Y.3
-
46
-
-
77950495945
-
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-prodige 2
-
Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-prodige 2. J Clin Oncol 2010;28:1638-1644.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1638-1644
-
-
Gerard, J.P.1
Azria, D.2
Gourgou-Bourgade, S.3
-
47
-
-
79960242791
-
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial
-
Aschele C, Cionini L, Lonardi S, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011;29:2773-2780.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2773-2780
-
-
Aschele, C.1
Cionini, L.2
Lonardi, S.3
-
48
-
-
84863106037
-
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
-
Rodel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012;13:679-687.
-
(2012)
Lancet Oncol
, vol.13
, pp. 679-687
-
-
Rodel, C.1
Liersch, T.2
Becker, H.3
-
49
-
-
80053103472
-
The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]
-
Roh MS, Yothers GA, O'Connell MJ, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]. J Clin Oncol 2011;29(Suppl):Abstract 3503.
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL.
-
-
Roh, M.S.1
Yothers, G.A.2
O'Connell, M.J.3
-
50
-
-
0042262630
-
Rectal resection with low anastomosis: Functional outcome
-
Matzel KE, Bittorf B, Gunther K, et al. Rectal resection with low anastomosis: functional outcome. Colorectal Dis 2003;5:458-464.
-
(2003)
Colorectal Dis
, vol.5
, pp. 458-464
-
-
Matzel, K.E.1
Bittorf, B.2
Gunther, K.3
-
51
-
-
0242410944
-
The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation
-
Temple LK, Wong WD, Minsky B. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol 2003;13:469-477.
-
(2003)
Semin Radiat Oncol
, vol.13
, pp. 469-477
-
-
Temple, L.K.1
Wong, W.D.2
Minsky, B.3
-
52
-
-
0034118502
-
Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation
-
Shibata D, Guillem JG, Lanouette N, et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 2000;43:752-758.
-
(2000)
Dis Colon Rectum
, vol.43
, pp. 752-758
-
-
Shibata, D.1
Guillem, J.G.2
Lanouette, N.3
-
53
-
-
0028144915
-
Long-term functional results of coloanal anastomosis for rectal cancer
-
discussion 94-95
-
Paty PB, Enker WE, Cohen AM, et al. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90-94; discussion 94-95.
-
(1994)
Am J Surg
, vol.167
, pp. 90-94
-
-
Paty, P.B.1
Enker, W.E.2
Cohen, A.M.3
-
54
-
-
2342504559
-
Are we overtreating rectal cancer: Time for another trial?
-
Carne PW, Nelson H. Are we overtreating rectal cancer: time for another trial? Ann Surg Oncol 2004;11:124-126.
-
(2004)
Ann Surg Oncol
, vol.11
, pp. 124-126
-
-
Carne, P.W.1
Nelson, H.2
-
55
-
-
0031947328
-
Effect of the introduction of total mesorectal excision for the treatment of rectal cancer
-
Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-529.
-
(1998)
Br J Surg
, vol.85
, pp. 526-529
-
-
Carlsen, E.1
Schlichting, E.2
Guldvog, I.3
-
56
-
-
0033504794
-
Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service
-
discussion 552-554
-
Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 1999;230:544-552; discussion 552-554.
-
(1999)
Ann Surg
, vol.230
, pp. 544-552
-
-
Enker, W.E.1
Merchant, N.2
Cohen, A.M.3
-
58
-
-
0035975394
-
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
-
(2001)
N Engl J Med
, vol.345
, pp. 638-646
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
59
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, R.M.1
Sargent, D.J.2
Morton, R.F.3
-
60
-
-
0034727063
-
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group
-
Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914.
-
(2000)
N Engl J Med
, vol.343
, pp. 905-914
-
-
Saltz, L.B.1
Cox, J.V.2
Blanke, C.3
-
61
-
-
2142703727
-
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
-
Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-1214.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1209-1214
-
-
Grothey, A.1
Sargent, D.2
Goldberg, R.M.3
Schmoll, H.J.4
-
62
-
-
33744971129
-
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer
-
Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006;29:219-224.
-
(2006)
Am J Clin Oncol
, vol.29
, pp. 219-224
-
-
Das, P.1
Skibber, J.M.2
Rodriguez-Bigas, M.A.3
-
63
-
-
11144332468
-
Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival
-
discussion 99-101
-
Habr-Gama A, Perez RO, Nadalin W, et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005;9:90-99; discussion 99-101.
-
(2005)
J Gastrointest Surg
, vol.9
, pp. 90-99
-
-
Habr-Gama, A.1
Perez, R.O.2
Nadalin, W.3
-
64
-
-
33644842988
-
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
-
Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8688-8696
-
-
Rodel, C.1
Martus, P.2
Papadoupolos, T.3
-
65
-
-
23444444903
-
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
-
Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-146.
-
(2005)
Histopathology
, vol.47
, pp. 141-146
-
-
Ryan, R.1
Gibbons, D.2
Hyland, J.M.3
-
66
-
-
79956219437
-
Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence
-
de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 2011;18:1590-1598.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 1590-1598
-
-
De Campos-Lobato, L.F.1
Stocchi, L.2
Da Luz Moreira, A.3
-
67
-
-
23444444903
-
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
-
Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-146.
-
(2005)
Histopathology
, vol.47
, pp. 141-146
-
-
Ryan, R.1
Gibbons, D.2
Hyland, J.M.3
-
68
-
-
79956159481
-
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
-
Topova L, Hellmich G, Puffer E, et al. Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. Dis Colon Rectum 2011;54:401-411.
-
(2011)
Dis Colon Rectum
, vol.54
, pp. 401-411
-
-
Topova, L.1
Hellmich, G.2
Puffer, E.3
-
69
-
-
84857572341
-
Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy
-
Huebner M, Wolff BG, Smyrk TC, et al. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg 2012;36:675-683.
-
(2012)
World J Surg
, vol.36
, pp. 675-683
-
-
Huebner, M.1
Wolff, B.G.2
Smyrk, T.C.3
-
70
-
-
84864003865
-
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer
-
Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 2012;30:1770-1776.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1770-1776
-
-
Park, I.J.1
You, Y.N.2
Agarwal, A.3
-
71
-
-
84867402398
-
Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: A meta-analysis
-
Zorcolo L, Rosman AS, Restivo A, et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 2012;19:2822-2832.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 2822-2832
-
-
Zorcolo, L.1
Rosman, A.S.2
Restivo, A.3
-
72
-
-
18244396398
-
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival
-
Onaitis MW, Noone RB, Fields R, et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001;8:801-806.
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 801-806
-
-
Onaitis, M.W.1
Noone, R.B.2
Fields, R.3
-
73
-
-
77950678271
-
Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
-
Sprenger T, Rothe H, Jung K, et al. Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification? World J Surg Oncol 2010;8:27.
-
(2010)
World J Surg Oncol
, vol.8
, pp. 27
-
-
Sprenger, T.1
Rothe, H.2
Jung, K.3
-
75
-
-
81055135326
-
-
NCCN.org. Accessed January 25, 2013
-
Benson AB III, Bekaii-Saab T, Chan E, et al. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 4, 2013. Available at: NCCN.org. Accessed January 25, 2013.
-
NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 4, 2013.
-
-
Benson Iii, A.B.1
Bekaii-Saab, T.2
Chan, E.3
|